Ethyl 3,5-dibromoisonicotinate, 97%, 250mg

(2R,4S)-1-((S)-2-Amino-3,3-dimethylbutanoyl)-4-hydroxy-N-((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)pyrrolidine-2-carboxamide hydrochloride, 98%, 100mg

(8-Phenyl-1,4-dioxaspiro[4.5]Decan-8-yl)methanamine, 95+%, 1g

4,6-Dibromo-3H-benzoimidazol-5-ylamine, 97.0%, 1g

5-Bromo-2-chloro-4-ethoxypyridine, 95.0%, 1g

(R)-4-Toluenesulfinamide, 95.0%, 1g

1-Bromo-2-(difluoromethyl)benzene (stabilised over Potassium Carbonate), 97.0%, 5g

4-[7,12,17-tris(4-chlorophenyl)-21,22,23,24-tetraazapentacyclo[16.2.1.1�,?.1?,��.1��,�?]tetracosa-1,3,5,7,9,11,13(22),14,16,18(21),19-undecaen-2-yl]phenol, 95%, 1g

ethyl 2-(3,4-dichlorophenyl)ethanecarboximidate hydrochloride, 95.0%, 2g

(-)-10,2-Camphorsultam>98.0%(GC)5g

tert-Butyl 2,5-diazabicyclo[4.1.0]heptane-2-carboxylate hydrochloride, 98%, 1g

4-Chloro-2-fluoro-5-nitrobenzoic acid, 95.0%, 10g

3,4-Dimethoxy-1-fluorobenzene, 98.0%, 100g